ask="2.75"
ask_size="2000"
average_daily_volume="1004120"
bid="2.59"
bid_size="600"
book_value="0.34"
change="-0.10"
change_from_200_day_moving_average="0.95"
change_from_50_day_moving_average="0.78"
change_from_52_week_high="-1.73"
change_From_52_week_low="1.54"
change_in_percent="-3.64%"
close="2.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-0.99"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-0.95"
ex_dividend_date="N/A"
float_shares="4532000"
high="2.75"
high_52_weeks="4.38"
last_trade_date="3/2/2017"
last_trade_price="2.65"
last_trade_size="1819"
last_trade_time="4:00pm"
low="2.56"
low_52_weeks="1.11"
market_capitalization="25.40M"
moving_average_200_day="1.70"
moving_average_50_day="1.87"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.71"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+55.67%"
percent_change_from_50_day_moving_average="+42.04%"
percent_change_from_52_week_high="-39.50%"
percent_change_from_52_week_low="+138.74%"
previous_close="2.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.11"
price_per_sales="51.80"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="441265"
weeks_range_52="1.11 - 4.38"
